0
2018
Immunoglobulin Market

Immunoglobulin Market

by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), Product Type (IgG, IgA, IgM, IgE, and IgD), and by Mode of Delivery (Intravenous and Subcutaneous): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Report Code: A02254
Pages: 220
Nov 2018 | 19703 Views
Author(s) : Onkar S
Tables: 133
Charts: 87
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Immunoglobulin Market

Request Now !

Immunoglobulin Market Overview:

The global immunoglobulin market was valued at $9,972.9 million in 2017 and is expected to reach $16,694.7 million by 2025, CAGR of  6.6% from 2018 to 2025. Immunoglobulin, also referred to as antibody is a protein produced by plasma cells and other lymphocytes. It is complex entity that exerts its immunomodulatory effect on different components of the immune system. It is obtained from blood through the process of fractionation and is purified for therapeutic and non-therapeutic applications. Different classes of immunoglobulin, IgG, IgA, IgD, IgE, and IgM, are used for the treatment of various immunological and neurological diseases. These immunoglobulins are administered through intravenous and subcutaneous modes of delivery.

The major factors that fuel the market growth during the forecast period include increase in geriatric population & number of hemophilic patients, improved immunoglobulin production owing to the emergence of advanced technologies, and enhanced purification techniques (with better plasma yield). Furthermore, surge in prevalence diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia & others are expected to boost the market growth. However, stringent government regulations toward immunoglobulin products and high risk of side effects owing to the use of immunoglobulin are expected to hamper the growth of the market.

Application segment review

Based on application, the immunoglobulin market is divided into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome, and others. The hypogammaglobulinemia segment was the highest contributor to the market in 2017 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the significant increase in prevalence of hypogammaglobulinemia disorder across the globe over the years. For instance, hypogammaglobulinemia is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs). Its incidence rate is ~2 per 100,000 population yearly, globally.

Mode of delivery segment review

Based on mode of delivery, the immunoglobulin market is classified into intravenous and subcutaneous. The intravenous segment accounted for the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. High bioavailability of immunoglobulins and rapid absorption rate offered by intravenous mode of delivery are the factors that supplement the growth of the intravenous mode of delivery immunoglobulin market.

Region segment review

Based on region, the immunoglobulin market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is the largest contributor toward the global market, followed by Asia-Pacific. These regions collectively occupy almost 75% of the global market revenue. Presence of the largest plasma production facilities and high adoption rate in the developed countries majorly boost the market growth. However, LAMEA is projected to register the highest growth rate during the forecast period.

The report provides extensive competitive analysis and profiles of key market players that includes Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., Shire (Baxalta), and Bayer Healthcare.

Other players in the value chain include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products Co., Ltd., Option Care Enterprises, Inc., ADMA Biologics, Inc., and BioScrip, Inc.

Key Benefits for Immunoglobulin Market:

  • The study provides an in-depth analysis of the global immunoglobulin market with the current trends and future estimations to elucidate the imminent investment pockets.

  • A comprehensive analysis of the factors that drive and restrict the market growth is provided.

  • A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

  • An extensive analysis of the key segments of the industry helps understand the trends in the global immunoglobulin treatment market.

  • Key players and their strategies are provided to understand the competitive outlook of the industry.

Immunoglobulin Key Market Segments:

By Application

  • Hypogammaglobulinemia

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Immunodeficiency Disease

  • Myasthenia Gravis

  • Multifocal Motor Neuropathy

  • Idiopathic Thrombocytopenic Purpura (ITP)

  • Inflammatory Myopathies

  • Specific Antibody Deficiency

  • Guillain‐Barré Syndrome

  • Others

By Product

  • IgG

  • IgA

  • IgM

  • IgE

  • IgD

By Mode of Delivery

  • Intravenous

    • 5% Concentration

    • 10% Concentration

    • Others

  • Subcutaneous

    • 16.5% Concentration

    • 20% Concentration

    • Others

By Region

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • France

    • Germany

    • Italy

    • Austria

    • Russia

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • LAMEA

    • Saudi Arabia

    • Argentina

    • Brazil

    • Turkey

    • Rest of LAMEA

 

Loading Table Of Content...


 
 

The immunoglobulin products gained significant attention in the recent years due to their efficacy in the treatment of immune diseases. Immunoglobulin is considered to be the most effective treatment for hypogammaglobulinemia, CIDP, and immunodeficiency diseases, which are the largest immunoglobulin consuming indications in the global immunoglobulin market, owing to the large patient population and unavailability of effective alternative treatments.

Presence of limited number of plasma donors hampers the market growth. To resolve this, immunoglobulin producers have appealed to the local government for favorable pricing policy in selective regions of the market and they have successfully gained support from government authorities. Therefore, the average price of immunoglobulin is projected to remain relatively stable during the forecast period.

Moreover, the substantial development in technology involved in plasma production and purification is expected to significantly increase the immunoglobulin production. In addition, the key players have decided to strengthen their research activities for the development of therapies for rare diseases through immunoglobulin products, which are anticipated to provide growth opportunities in the immunoglobulin market.

The administration of immunoglobulin is the highest in North America, owing to the increase in adoption of immunoglobulin products, high awareness regarding the benefits of using immunoglobulin therapies among the healthcare providers, and increase in disposable income among patients. Although the use of immunoglobulin in LAMEA is low, the adoption rate is expected to increase due to rise in disposable income, surge in healthcare expenditure, and government initiative to enhance the healthcare departments. These factors contribute toward the market growth.

 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample

Purchase Full Report of
Immunoglobulin Market

Start reading instantly.
This Report and over 19,654+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Nov 2019 - Nov 2020)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2019 - Nov 2020)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2019 - Nov 2020)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2019 - Nov 2020)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2019 - Nov 2020)
  • Library
    Membership

  • $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers